Document is current

Article History

Received: 30 June 2026

Accepted: 24 August 2026

First Online: 8 September 2026

Declarations

Conflict of Interest: Lenka V. Hurton is an employee and stock/options holder for Castle Biosciences, Inc. Joshua Burshtein received fellowship funds from Castle Biosciences, Inc. Aaron S. Farberg is a consultant for Castle Biosciences, Inc. and on the advisory board for Amgen, Boehringer Ingelheim, Eli Lilly, Galderma, Incyte, Janssen, Novartis, Ortho Dermatologics, Pfizer, and Sun Pharma; is an editorial board member of Dermatology and Therapy and was not involved in the selection of peer reviewers nor any subsequent editorial decisions. Peter A. Lio reports research grants/funding from AbbVie, AOBiome, Eczema Foundation, National Eczema Association; is on the speaker's bureau for AbbVie, Eli Lilly, Galderma, Hyphens Pharma, Incyte, La Roche-Posay/L’Oreal, MyOR Diagnostics, ParentMD, Pfizer, Pierre-Fabre Dermatologie, Regeneron/Sanofi Genzyme; reports consulting/advisory boards for AbbVie, Almirall, Amyris, Arbonne, ASLAN, Bodewell, Boston Skin Science, Bristol-Myers Squibb, Burt’s Bees, Castle Biosciences, Inc., Codex Labs, Concerto Biosci, Dermavant, Dermira, DermVeda, Eli Lilly, Galderma, IntraDerm, Janssen, Johnson & Johnson, Kaleido Biosci, Kimberly Clark, LEO Pharma, Lipidor, L’Oreal, Menlo Therapeutics, Merck, Micreos, MyOR Diagnostics, Regeneron/Sanofi Genzyme, Sibel Health, Skinfix, Sonica, Theraplex, UCB, Unilever, Verrica, Yobee Care; stock options with LearnSkin/Learn Health, Medable, Micreos, Modernizing Medicine, Yobee Care. In addition, Peter A. Lio has a patent pending for a Theraplex product with royalties paid and is a Board member and Scientific Advisory Committee Member of the National Eczema Association. Diego Ruiz Dasilva is a consultant/speaker for AbbVie, Arcutis, Dermavant/Organon, Galderma, Incyte, Johnson & Johnson, LEO, Pfizer, Regeneron, Sanofi, UCB, Takeda, Eli Lilly, Verica, Vanta Diagnostics & Castle Biosciences, Inc. John Koo is a speaker for Abbvie, Amgen, BMS, Eli Lilly, Gelderma, Leo, Pfizer, Regeneron, Sanofi, Sun, a consultant for Castle Biosciences, Inc., Janssen, Leo and Sun. AF is a consultant or advisor for Kenvue, Galderma Laboratories, L.P., Hoth Therapeutics, Incyte Corporation, Johnson & Johnson, La-Roche Posay, Lilly, L'Oréal S.A., MINO Labs, Novartis, Novocure, Pfizer, Inc., Regeneron Pharmaceuticals, Inc., Sanofi, Leo Pharma, Arcutis Abbvie; reports research funding from: Galderma Laboratories, L.P., Incyte Corporation, Janssen, MINO Labs, Pfizer, Inc.; is on speakers bureau for: Incyte Corporation, Johnson & Johnson, Lilly, Regeneron Pharmaceuticals, Inc., Sanofi, Novartis, Arcutis, Pfizer, and UCB Pharma, Inc.

Ethical Approval: Participation in the survey was voluntary. Informed consent to participate was obtained from all participants prior to their inclusion in the study. Participants were provided a link to complete the survey that was not participant-specific. Risk to participants was considered minimal as no protected health information or identifying information was collected.